Breaking News Instant updates and real-time market news.

ANAB

AnaptysBio

$38.53

0.82 (2.17%)

08:06
11/04/19
11/04
08:06
11/04/19
08:06

AnaptysBio can rally 100% on positive atopic dermatitis data, says Jefferies

Shares of AnaptysBio can rally 80%-100% on positive Phase IIb data for etokimab in atopic dermatitis, which is expected before year-end 2020, Jefferies analyst Biren Amin tells investors in a research note. The overall trial design mirrors Dupixent Phase III trials, with similar enrollment criteria, treatment period, and limit on rescue steroid use, the analyst points out. Amin, who sees 50% share downside on inferior data, keeps a Buy rating on AnaptysBio with a $120 price target.

ANAB AnaptysBio
$38.53

0.82 (2.17%)

10/01/19
CANT
10/01/19
NO CHANGE
Target $140
CANT
Overweight
AnaptysBio data 'encouraging,' selloff today overdone, says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle thinks AnaptysBio's new ANB019 data show "very clear signs of activity in a very severe, difficult-to-treat population." The analyst, however, thinks investors will be surprised by the limited data, given it contained only two patients versus the study of up to 10, and have questions about the one case of bacteremia. Given the severity of generalized pustular psoriasis, Merle believes the one case of bacteremia was likely due to the underlying disease. She views the data as "encouraging" the corresponding stock selloff as overdone. The analyst reiterates an Overweight rating on AnaptysBio with a $140 price target. The stock in premarket trading is down 13%, or $4.44, to $30.55.
10/01/19
JPMS
10/01/19
NO CHANGE
JPMS
Overweight
AnaptysBio data set shows 'compelling' early trends, says JPMorgan
While the two patient sample size is disappointing relative to the mid-single-digit range expectation, AnaptysBio's interim analysis of the Phase 2 Gallop trial of ANB019 in generalized pustular psoriasis showed "interesting / compelling early trends," JPMorgan analyst Anupam Rama tells investors in a research note. Both patients achieved reductions of 50% or greater on modified Japanese Dermatology Association scores at day eight through day 11, adds the analyst. Rama wants to await a larger data set before making more definitive conclusions on the ANB019 opportunity in generalized pustular psoriasis but he keeps an Overweight rating on AnaptysBio shares.
10/01/19
GUGG
10/01/19
NO CHANGE
GUGG
Buy
AnaptysBio data for ANB019 'very early,' but looks promising, says Guggenheim
Guggenheim analyst Yatin Suneja noted that AnaptysBio shared early data from the Phase 3 GALLOP trial of ANB019 to treat generalized pustular psoriasis, or GPP. The data were from only two patients, and investors were hoping to see more, said Suneja, who added that ANB019 was effective at driving down disease in those two patients. The data is "generally promising," but Suneja believes investors will be hesitant to assign any value to this program until a more complete dataset is shared, noting that the next update on GALLOP will not be until 2020. The analyst keeps a Buy rating on AnaptysBio shares.
10/03/19
FBCO
10/03/19
NO CHANGE
Target $48
FBCO
Neutral
AnaptysBio price target lowered to $48 from $75 at Credit Suisse
Credit Suisse analyst Martin Auster lowered his price target for AnaptysBio to $48 from $75 after removing ANB019 from his NPV and folding it into his pipeline value pending additional data and clarity on a path forward. The analyst reiterates a Neutral rating on the shares.

TODAY'S FREE FLY STORIES

GLD

SPDR Gold Shares

$137.59

-1.42 (-1.02%)

17:55
12/06/19
12/06
17:55
12/06/19
17:55
Hot Stocks
SPDR Gold Shares holdings fall to 886.23MT from 888.57MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PICO

PICO Holdings

$10.81

0.31 (2.95%)

17:45
12/06/19
12/06
17:45
12/06/19
17:45
Hot Stocks
PICO Holdings sells long-term storage credits for $8.7M in Arizona »

PICO Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QHC

Quorum Health

$0.95

0.0522 (5.81%)

17:31
12/06/19
12/06
17:31
12/06/19
17:31
Hot Stocks
Quorum Health receives NYSE continued listing standard notice »

Quorum Health Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:30
12/06/19
12/06
17:30
12/06/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BXRX

Baudax Bio

$6.69

0.34 (5.35%)

17:29
12/06/19
12/06
17:29
12/06/19
17:29
Syndicate
Breaking Syndicate news story on Baudax Bio »

Baudax Bio files $125M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

LMT

Lockheed Martin

$387.10

1.175 (0.30%)

17:25
12/06/19
12/06
17:25
12/06/19
17:25
Hot Stocks
Lockheed Martin awarded $153.39M Navy contract modification »

Lockheed Martin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENV

Envestnet

$71.72

1.27 (1.80%)

17:23
12/06/19
12/06
17:23
12/06/19
17:23
Syndicate
Breaking Syndicate news story on Envestnet »

Envestnet files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOC

Northrop Grumman

$344.79

0.4 (0.12%)

17:20
12/06/19
12/06
17:20
12/06/19
17:20
Hot Stocks
Northrop Grumman awarded $189M Navy contract modification »

Northrop Grumman was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:03
12/06/19
12/06
17:03
12/06/19
17:03
Hot Stocks
Support.com announces special distribution of $1.00 per share »

The record date for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPRT

Support.com

$1.94

0.01 (0.52%)

17:01
12/06/19
12/06
17:01
12/06/19
17:01
Hot Stocks
Breaking Hot Stocks news story on Support.com »

Support.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RZLT

Rezolute

$0.00

(0.00%)

17:00
12/06/19
12/06
17:00
12/06/19
17:00
Syndicate
Breaking Syndicate news story on Rezolute »

Rezolute files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,750.79

10.2 (0.59%)

16:58
12/06/19
12/06
16:58
12/06/19
16:58
Periodicals
U.S. mulls putting Amazon foreign sites on 'Notorious Markets' list, WSJ says »

The Trump administration…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGTA

Magenta Therapeutics

$13.29

0.3 (2.31%)

16:55
12/06/19
12/06
16:55
12/06/19
16:55
Conference/Events
Magenta Therapeutics to hold an investor and analyst event »

Investor and Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 07

    Dec

IMH

IMPAC Mortgage

$5.63

-0.01 (-0.18%)

16:54
12/06/19
12/06
16:54
12/06/19
16:54
Syndicate
Breaking Syndicate news story on IMPAC Mortgage »

IMPAC Mortgage files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.74

0.33 (1.70%)

16:32
12/06/19
12/06
16:32
12/06/19
16:32
Hot Stocks
Alector reports Phase 1 safety, biomaker data on AL002 »

Alector reported safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATAX

America First Multifamily Investors

$7.58

0.125 (1.68%)

16:31
12/06/19
12/06
16:31
12/06/19
16:31
Hot Stocks
America First Multifamily Investors CFO Craig Allen to retire »

On December 2,Craig Allen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
12/06/19
12/06
16:30
12/06/19
16:30
Options
Preliminary option volume of 20.4M today »

Preliminary option volume…

PNM

PNM Resources

$48.77

-0.06 (-0.12%)

16:29
12/06/19
12/06
16:29
12/06/19
16:29
Hot Stocks
PNM Resources raises quarterly dividend 6% to 30.75c per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MORN

Morningstar

$154.47

-0.25 (-0.16%)

16:22
12/06/19
12/06
16:22
12/06/19
16:22
Hot Stocks
Morningstar raises quarterly dividend 7.1% to 30c from 28c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACEL

Alfacell Corporation

$11.11

0.1 (0.91%)

16:22
12/06/19
12/06
16:22
12/06/19
16:22
Hot Stocks
Crescent Park Management reports 6.4% passive stake in Accell »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

O

Realty Income

$75.96

0.31 (0.41%)

16:21
12/06/19
12/06
16:21
12/06/19
16:21
Syndicate
Breaking Syndicate news story on Realty Income »

Realty Income files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
12/06/19
12/06
16:20
12/06/19
16:20
Options
Closing CBOE SPX and VIX Index summary for December 6th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

, BMY

Bristol-Myers

$59.94

0.435 (0.73%)

16:19
12/06/19
12/06
16:19
12/06/19
16:19
Hot Stocks
Bristol-Myers, Bluebird Bio: Phase 2 KarMMa study of ide-cel met endpoints »

Bristol-Myers Squibb…

BLUE

Bluebird Bio

$79.51

-1.24 (-1.54%)

BMY

Bristol-Myers

$59.94

0.435 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

  • 09

    Dec

  • 11

    Dec

UBER

Uber

$27.87

-0.775 (-2.71%)

, ALXN

Alexion

$113.86

6.44 (6.00%)

16:18
12/06/19
12/06
16:18
12/06/19
16:18
On The Fly
Fly Intel: Wall Street's top stories for Friday »

For the first day in what…

UBER

Uber

$27.87

-0.775 (-2.71%)

ALXN

Alexion

$113.86

6.44 (6.00%)

MMM

3M

$171.43

7.07 (4.30%)

ICE

IntercontinentalExchange

$93.81

0.17 (0.18%)

TTD

Trade Desk

$247.63

7.36 (3.06%)

BIG

Big Lots

$25.22

6.05 (31.56%)

ULTA

Ulta Beauty

$262.19

26.1 (11.06%)

CIEN

Ciena

$35.01

-1.29 (-3.55%)

PD

PagerDuty

$21.81

-3.185 (-12.75%)

YEXT

Yext

$14.26

-2.355 (-14.17%)

ZM

Zoom Video

$62.76

-6.97 (-10.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 10

    Dec

  • 12

    Dec

  • 16

    Dec

  • 16

    Dec

  • 12

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
12/06/19
12/06
16:17
12/06/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.